Holocene Advisors, LP Catalent, Inc. Transaction History

Holocene Advisors, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$45.44 - $74.26 $17.4 Million - $28.4 Million	381,878 Added 6575.03%	387,686 $25.5 Million
Q4 2022 Feb 14, 2023	BUY	$41.39 - $81.0 $240,393 - $470,448	5,808 New	5,808 $261,000
Q4 2021 Feb 14, 2022	SELL	$119.57 - $139.07 $197,170 - $229,326	-1,649 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$109.17 - $142.35 $180,021 - $234,735	1,649 New	1,649 $219,000

513

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

Stay updated on Holocene Advisors, LP with notifications on news.